Plastin-3 (PLS3)–one of the first SMN2-independent modifier genes identified for SMA–mRNA levels were found to be higher in females with milder SMA than those siblings with a more severe SMA clinical presentation (44–49). This evidence concerns the gene PLS3 and proximal spinal muscular atrophy.